June 4, 2018

New guidelines for HER2 testing in breast cancer

An image of the HER2 protein.

Current HER2 tests help predict which breast cancer patients will respond to HER2-targeted therapies, but sometimes these tests provide unclear results. An Expert Panel of pathologists and cancer researchers, including Dr. John Bartlett from OICR, recently published revised clinical practice guidelines for HER2 testing in breast cancer to help improve clarity of HER2 test results.

Continue reading – New guidelines for HER2 testing in breast cancer

April 13, 2017

Could diagnosing cancer as rare diseases improve outcomes for patients?

Dr. John Bartlett

Breast cancer is the most common form of cancer amongst women in Canada and worldwide, but despite its prevalence, a group of researchers believes that it should often be treated as a rare disease. Doing so would change clinical approaches and improve treatment for patients.

Continue reading – Could diagnosing cancer as rare diseases improve outcomes for patients?

August 11, 2016

OICR’s Geoff Fong receives major funding to examine e-cigarettes and the impact of public health policy

Around the world it has become common to walk down the street and see a new trend – people vaping (using e-cigarettes). The widespread use of e-cigarettes has caught the attention of the scientific community. Recently, OICR Investigator Dr. Geoff Fong was awarded funding from Canadian and U.S. federal funding agencies to evaluate the impact of e-cigarettes and determine the effectiveness of policies around their use.

Continue reading – OICR’s Geoff Fong receives major funding to examine e-cigarettes and the impact of public health policy